Observational, retrospective and prospective, multicenter, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are prescribed renal replacement therapy \> 12 hours.
Study Type
OBSERVATIONAL
Enrollment
33
Renal Replacement Therapy between 12\< to ≤ 24 hours.
St. Mark's Hospital
Salt Lake City, Utah, United States
Treatment Success
Percentage of treatments achieving prescribed dialysis treatment time ≤ 10%
Time frame: Up to 24 hours
Tablo Cartridge Life
Measure the average number of cartridge changes required to complete a Tablo XT Treatment
Time frame: up to 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.